Gainers & Losers Of The Day: APRI, LIFE, JAZZ, ETRM, BIOC...

Lilly is all set to acquire CoLucid Pharma for $46.50 per share in cash or approximately $960 million.

from RTT - Biotech http://ift.tt/2jaBJWs
via IFTTT